Daniel Torrent: From Early Hemodynamic Recovery to Improved Survival in Pulmonary Embolism
Daniel Torrent, Vascular Surgeon at Longstreet Clinic, shared a post on LinkedIn about recent article by Ryan Nolan et al. published in Journal of Vascular and Interventional Radiology adding:
“The recent results from the STORM-PE trial have established a new benchmark in Pulmonary Embolism (PE) care, providing Level 1 evidence that mechanical thrombectomy (MT) significantly reduces right heart strain (RV/LV ratio) compared to anticoagulation alone.
However, as with many randomized controlled trials, critics often point to the use of surrogate endpoints and wonder: does this physiological recovery actually translate to saving lives?
A new retrospective analysis by Nolan et al. provides a compelling ‘real-world’ answer that further validates the STORM-PE findings.
While STORM-PE showed us that we can rapidly offload the failing right ventricle, this study demonstrates the downstream clinical impact: a significant 30-day mortality benefit.
The Key Findings: From Physiology to Survival
This retrospective study of 335 patients with intermediate-high and high-risk PE (evaluated by a Pulmonary Embolism Response Team) highlights why MT is becoming the frontline choice:
Mortality Benefit: The use of MT was associated with a 51% reduction in the odds of 30-day all-cause mortality (OR 0.49; 95% CI, 0.27-0.76; $P=.002).
Faster Recovery: Patients in the MT+AC cohort had a hospital length of stay (LOS) that was 2 days shorter on average (P<.001).
Reduced Morbidity: MT patients were significantly less likely to require supplemental oxygen at discharge (4.1% vs 18.5%, P<.001).
Long-Term Outlook: MT was associated with a 36.4% reduced hazard of death throughout the study period.
Bridging the Gap: STORM-PE and Real-World Evidence
STORM-PE proved that computer-assisted vacuum thrombectomy (CAVT) is superior at normalizing the RV/LV ratio within 48 hours. This retrospective data bridges the gap by showing that these early hemodynamic improvements correlate with the hard outcomes we care about most—keeping patients alive and getting them home sooner.
The combination of Level 1 surrogate data and large-scale retrospective survival data makes a powerful case: mechanical thrombectomy is no longer just an “option” for high-risk and intermediate high risk PE; it is a vital tool for improving survival.
The takeaway for PERT teams? The early physiological wins we see in the lab are translating into real-world lives saved.”
Title: Clinical Outcomes following Mechanical Thrombectomy in Pulmonary Embolism Response Team–Consulted Patients: A Retrospective Analysis
Authors: Ryan Nolan, Maanasi Samant, Suresh Vedantham, Westley Ohman, Nathan Droz, Kristen Sanfilippo, Pavan Kavali
Read the Full Article on Journal of Vascular and Interventional Radiology.
Find more posts featuring Daniel Torrent on Hemostasis Today.
-
May 6, 2026, 14:02Abdul Mannan: Anemia in Myelofybrosis – Five Fires Behind One Falling Hb
-
May 6, 2026, 14:00Mona Alfaraj: Advancing Care in Inherited Platelet Disorders at 2nd International Hematology and Hemostasis Conference
-
May 6, 2026, 13:56Mahesan Subramaniam: Why Delayed Cord Clamping Benefits Newborn Health
-
May 6, 2026, 13:44Wolfgang Miesbach: Octreotide as a First‑Line Systemic Option in VWD Patients With Angiodysplasia‑Related GI Bleeding
-
May 6, 2026, 13:42Irogue Igbinosa: Rethinking Iron Deficiency in Pregnancy with Intravenous Therapy
-
May 6, 2026, 13:34Manaf Aljishi: Three Posters Presented at the Hematology and Hemostasis Conference 2026
-
May 6, 2026, 13:33David Ferreira: Insights from the 1st National Meeting of Young Immunohematologists in Abrantes
-
May 6, 2026, 13:22Nicholas Lee: Honored to Join ASH CRTI Program for Aplastic Anemia Research
-
May 6, 2026, 13:16Mehari Gebreyohanns: Transition from Alteplase to Tenecteplase Is Full Steam Ahead in Texas